(Q38293477)

1 September 2017

1 reference

title

Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions (English)

1 reference

1 September 2017

0 references

systemic inflammation

1 reference

Nicoletta Ronda

4

0 references

Giuseppe Danilo Norata

object named as

Giuseppe Danilo Norata

3

0 references

Fabrizio Montecucco

object named as

Fabrizio Montecucco

1

0 references

author name string

Elda Favari

2

1 reference

PubMed ID

25522998

1 September 2017

Jerzy-Roch Nofer

5

1 reference

PubMed ID

25522998

1 September 2017

Nicolas Vuilleumier

6

1 reference

1 September 2017

1 January 2015

1 reference

Handbook of experimental pharmacology

1 September 2017

1 reference

1 September 2017

224

1 reference

1 September 2017

455-482

1 reference

Creative Commons Attribution-NonCommercial 2.5 Generic

1 September 2017

start time

1 December 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Natural regulatory T cells control the development of atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Postsurgical reduction of serum lipoproteins: interleukin-6 and the acute-phase response

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Circulating CD4+CD25hiCD127lo regulatory T-Cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Both apolipoprotein E and A-I genes are present in a nonmammalian vertebrate and are highly expressed during embryonic development

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Role of regulatory T cells and FOXP3 in human diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Apolipoprotein A-I binding to anionic vesicles and lipopolysaccharides: role for lysine residues in antimicrobial properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Can TNF-α boost regulatory T cells?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Mechanisms of dyslipoproteinemias in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Depleted mucosal antioxidant defences in inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Apolipoprotein A-I attenuates palmitate-mediated NF-κB activation by reducing Toll-like receptor-4 recruitment into lipid rafts

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Induction of MCP1, CCR2, and iNOS expression in THP-1 macrophages by serum of children late after Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Sphingosine-1-phosphate and immune regulation: trafficking and beyond

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Changes in plasma levels of lipids and lipoprotein composition in patients with Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Serum Lipid, Lipoprotein and Oxidatively Modified Low Density Lipoprotein Levels in Active or Inactive Patients with Behçet's Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

HDL and CETP Inhibition: Will This DEFINE the Future?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Systemic lupus erythematosus and "lupus dyslipoproteinemia".

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Endothelial dysfunction late after Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Major lipids, apolipoproteins, and risk of vascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Statins for Atherosclerosis — As Good as It Gets?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

High-density lipoprotein particle size and concentration and coronary risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Lipoprotein lipase activity in rat cardiomyocytes is stimulated by insulin and dexamethasone

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Risk of Myocardial Infarction in Patients With Psoriasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Apolipoprotein A-I mimetics and high-density lipoprotein function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Blockade of T cell contact-activation of human monocytes by high-density lipoproteins reveals a new pattern of cytokine and inflammatory genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Dissociation of the high density lipoprotein and low density lipoprotein binding activities of murine scavenger receptor class B type I (mSR-BI) using retrovirus library-based activity dissection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Lipid rafts and B cell signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Inflammation, high-density lipoprotein and cardiovascular dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Hormonal regulation of apolipoprotein AI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Cellular cholesterol homeostasis in vascular endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

The HDL proteome: a marker--and perhaps mediator--of coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Psoriasis alters HDL composition and cholesterol efflux capacity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE‐related cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Investigation of the mechanisms involved in the high-dose and long-term acetyl salicylic acid therapy of type I diabetic rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

High-density lipoprotein profiling changes in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

High-density lipoproteins are abnormal in young women with uncomplicated systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Lipid rafts and T-lymphocyte function: implications for autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Effects of tumor necrosis factor alpha inhibition with infliximab on lipid levels and insulin resistance in patients with inflammatory bowel disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

In vivo protection against endotoxin by plasma high density lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Regulation of Epstein-Barr virus latency by latent membrane protein 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Acute inflammatory state during influenza infection and endothelial function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Dyslipidemia in the critically ill.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Effects of 14 weeks of TNF alpha blockade treatment on lipid profile in ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Inflammation impairs reverse cholesterol transport in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Atherogenic lipid profile in Behçet's disease: evidence of alteration of HDL subclasses

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Lipid profile and anticardiolipin antibodies in Behcet's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Altered lipid profile after Kawasaki syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

HDL and adaptive immunity: a tale of lipid rafts

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Emerging role of high density lipoproteins as a player in the immune system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Cellular physiology of cholesterol efflux in vascular endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

New insights into the determination of HDL structure by apolipoproteins: Thematic review series: high density lipoprotein structure, function, and metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

The role of cholesterol efflux in mechanisms of endothelial protection by HDL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

The alliance of sphingosine-1-phosphate and its receptors in immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Plasma lipids and inflammation in active inflammatory bowel diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Prevalence of classical CD14++/CD16- but not of intermediate CD14++/CD16+ monocytes in hypoalphalipoproteinemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

HDL: bridging past and present with a look at the future

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

The effect of aspirin on atherogenic diet-induced diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Causal relevance of blood lipid fractions in the development of carotid atherosclerosis: Mendelian randomization analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Accelerated atherosclerosis in autoimmune rheumatic diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Psoriasis is associated with increased intima-media thickness--the Study of Health in Pomerania (SHIP).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Effect of lipid-bound apoA-I cysteine mutants on lipopolysaccharide-induced endotoxemia in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Regulation of macrophage function by sphingosine-1-phosphate.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Tissue destruction by neutrophils

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Serum metabolic profiling in inflammatory bowel disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Plasma sphingosine 1-phosphate metabolism and analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Effects of naproxen and nabumetone on serum cholesterol levels in patients with osteoarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

Ibuprofen inhibits adhesiveness of monocytes to endothelium and reduces cellular oxidative stress in smokers and non-smokers

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_14

10.1007/978-3-319-09665-0_14

31 March 2020

Identifiers

DOI

1 reference

1 September 2017

1 reference

PubMed ID

25522998